Exchange: NASDAQ·Updated 07:58 PM EDT

SCTXScribe Therapeutics

$21.65
$6.65
(44.33%)
Today
Closed $21.65
$0.24
(1.11%)
After Hours
Mkt Cap$350.34M
Vol990,795.00

About

Scribe Therapeutics, Inc. is a clinical-stage biotechnology company. It is engaged in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded in June 2017 by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Alameda, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
98

Frequently Asked Questions

What is Market Cap of Scribe Therapeutics Inc.?
What is the 52-week high for Scribe Therapeutics Inc.?
What is the 52-week low for Scribe Therapeutics Inc.?
What is Scribe Therapeutics Inc. stock price today?
What was Scribe Therapeutics Inc. stock price yesterday?
What is the Price-to-Book ratio of Scribe Therapeutics Inc.?
What is the 50-day moving average of Scribe Therapeutics Inc.?
How many employees does Scribe Therapeutics Inc. have?

Advertisement|Remove ads.